Catalyst
Slingshot members are tracking this event:
Aduro Biotech (ADRO) to file IND for Anti-APRIL treatment for tumor growth and immune suppression in multiple myeloma, in second half of 2017
- Source Link:
- https://seekingalpha.com/filing/3351398
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ADRO | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2017
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT03340883
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ind Filing, Anti-april, Multiple Myeloma
